UNSPSC 51402003: Meprobamate

This classification denotes a sedative, hypnotic, and anticonvulsant agent with the molecular formula C9H18N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9I7LNY769Q, chemically known as 1,3-propanediol, 2-methyl-2-propyl-, carbamate isopropylcarbamate (ester) but generally known as meprobamate, which bears US NIH Compound Identifier 2576. European Medicines Agency schedules Meprobamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08757MIG.

UNSPSC 51402003 Meprobamate is a Commodity code that does not align with the state and local procurement activity currently tagged to it. The single recent opportunity in the block—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—involves emergency-response pharmaceuticals and harm-reduction equipment wholly unrelated to meprobamate, a sedative medication with limited modern clinical use. The mismatch between the code's nominal scope and the actual work being solicited suggests either a tagging error in the source database or that meprobamate procurement does not drive meaningful state and local government buying activity at this time.

The Seminole County naloxone procurement (IFB posted June 30, 2026, response due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, fixed-fee pricing, drug-free workplace and E-Verify compliance, and a two-year initial term with one-year renewal option, potentially funded through FEMA. No additional state or local opportunities under this Commodity code appear in the available records. Until the tagging or sourcing issue clarifies, practitioners should treat this code as showing no reliable signal for meprobamate procurement and verify the correct UNSPSC classification for actual pharmaceutical supply opportunities before building pipeline activity.